By receiving your generous support CTRT can run a comprehensive program of clinical trials for patients with melanoma and renal cancer. This allows our patients access to the most modern treatments whilst also improving our understanding of the diseases we treat and identification of opportunities to improve outcomes.
The research team is led by Dr Paul Nathan (melanoma and renal cancer), Dr Heather Shaw (melanoma) and Dr Anand Sharma (renal cancer). We have a dedicated team that run all aspects of clinical trials from patient care to data management. However 80% of their salaries are covered by charitable funds and commercial trial income, only one salary is received from the national cancer research network. Our patients, therefore, have access to the most innovative treatments because of the generosity of contributors to CTRT.